Relmada Therapeutics, Inc. RLMD Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s interest income?
- Relmada Therapeutics, Inc. (RLMD) reported interest income of $959.76K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s interest income changed year-over-year?
- Relmada Therapeutics, Inc.'s interest income increased by 118.0% year-over-year, from $440.29K to $959.76K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s interest income?
- Over 2 years (2023 to 2025), Relmada Therapeutics, Inc.'s interest income has grown at a -47.9% compound annual growth rate (CAGR), from $5.15M to $1.4M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.